Market Definition

Angiography devices are medical imaging tools used to visualize blood vessels and internal organs, primarily to identify blockages, abnormalities, or vascular conditions. The market includes angiography systems, catheters, guide wires, contrast media injectors, and related accessories, supporting diagnostic and interventional procedures in hospitals, clinics, and specialized cardiovascular centers.

The report outlines the primary drivers of market growth, along with an in-depth analysis of emerging trends and evolving regulatory frameworks shaping the industry's trajectory.

Angiography Devices Market Overview

The global angiography devices market size was valued at USD 10.54 billion in 2024 and is projected to grow from USD 10.96 billion in 2025 to USD 15.18 billion by 2032, exhibiting a CAGR of 4.54% during the forecast period.

The market is expanding due to the increased use of advanced imaging in diagnostic and interventional procedures. Growing awareness of preventive care and the rise in image-guided treatments are fueling adoption. Healthcare providers are focusing on early and accurate detection of vascular conditions.

Major companies operating in the angiography devices industry are Siemens AG, General Electric Company, Koninklijke Philips N.V., Canon Inc., Shimadzu Corporation, Omega Medical Imaging, LLC, Allengers, Boston Scientific Corporation, AngioDynamics, Abbott, B. Braun SE, Cordis, TERUMO CORPORATION, Merit Medical Systems, and Alvimedica.

The integration of advanced imaging technologies in cancer care is expanding access to high-precision diagnostics and treatment, particularly in emerging healthcare markets. These technologies are revolutionizing the detection and management of complex conditions by enabling real-time visualization, reduced procedural risk, and improved therapeutic outcomes.

In June 2025, Tata Memorial Centre signed a Memorandum of Understanding with Powergrid Corporation of India to provide a Digital Subtraction Angiography (DSA) system to Tata Memorial Hospital under a Corporate Social Responsibility (CSR) initiative. The advanced DSA-CT system will enhance minimally invasive cancer diagnostics and treatment, improving access to timely and precise care.

Angiography Devices Market Size & Share, By Revenue, 2025-2032

Key Highlights

The angiography devices market size was valued at USD 10.54 billion in 2024.
The market is projected to grow at a CAGR of 4.54% from 2025 to 2032.
North America held a market share of 34.09% in 2024, with a valuation of USD 3.59 billion.
The consumables segment garnered USD 6.32 billion in revenue in 2024.
The x-ray segment is expected to reach USD 5.49 billion by 2032.
The coronary segment is projected to generate a valuation of USD 4.27 billion by 2032.
The hospitals segment is likely to register a value of USD 6.34 billion by 2032.
Asia Pacific is anticipated to grow at a CAGR of 5.51% over the forecast period.

Market Driver

Surging Adoption of Minimally Invasive Interventions

The market is witnessing strong growth due to the increasing adoption of minimally invasive, image-guided procedures. These techniques reduce surgical risks, shorten hospital stays, and improve patient outcomes, making them a preferred choice for both clinicians and patients.

As the focus shifts toward accuracy and efficiency in vascular diagnostics and treatment, there is a rising demand for high-precision angiography systems. These systems provide real-time, detailed imaging that enhances procedural control and decision-making.

The transition to advanced interventional methods is compelling healthcare providers to invest in next-generation angiography equipment, which is accelerating market expansion.

In August 2023, Canon Medical launched the Alphenix / Evolve Edition angiography system across Japan, Asia, Africa, and Europe. Designed for interventional cardiology, it features real-time AI via αEvolve technology to enhance imaging, reduce radiation, and improve procedural efficiency.

Market Challenge

Diagnostic Limitations in Microvascular Imaging

A major challenge hindering the expansion of the angiography devices market is the limited diagnostic accuracy in detecting microvascular disease, particularly in early or asymptomatic stages.

Conventional imaging techniques often lack the resolution and sensitivity to visualize small vessels and subtle abnormalities, which can result in delayed diagnosis or misinterpretation. This diagnostic limitation negatively impacts the success of interventional procedures and can lead to suboptimal patient outcomes.

To address this, manufacturers are integrating AI-enhanced imaging technologies into angiography systems. These innovations offer superior image clarity, automated detection, and real-time analysis, allowing clinicians to identify microvascular conditions with greater precision and efficiency. This advancement is improving diagnostic confidence and enabling more accurate, personalized treatment planning.

In March 2025, AngioInsight, Inc. launched the SMARTFLOW clinical study to evaluate its AI-powered AngioAI+ platform. The software enhances angiography image interpretation with features such as 3D reconstruction, non-invasive FFR estimation, and CMD detection. The study supports regulatory approval and aims to improve cardiovascular diagnosis, particularly for underdiagnosed female CMD patients.

Market Trend

Integration of Robotic Imaging Systems in Hybrid Surgical Settings

The market is witnessing a notable shift toward the use of advanced imaging technologies in hybrid operating room (OR) settings. This trend is further supported by the installation of fixed robotic angiography systems that offer enhanced precision and control.

These systems are increasingly being integrated into multi-functional surgical environments to support a wide range of vascular and endovascular procedures. The hybrid OR model enables seamless collaboration between surgical and imaging functions, improving workflow efficiency.

This trend reflects the broader move toward image-guided, minimally invasive interventions that demand high-resolution, real-time visualization capabilities.

In January 2025, the Salisbury VA Medical Center in North Carolina inaugurated a hybrid interventional operating room equipped with a fixed robotic angiography system from Siemens. Established in collaboration with Atrium Health Wake Forest Baptist, the facility enhances advanced imaging capabilities and minimally invasive vascular interventions, improving specialized care access for Veterans.

Angiography Devices Market Report Snapshot

Segmentation	Details
By Product	Systems, Consumables (Catheters, Guidewire, Contrast Media, Vascular Closure Devices, Accessories)
By Technology	X-Ray, MRA, CT, Others
By Application	Coronary, Endovascular, Neurovascular, Cerebral, Others
By End User	Hospitals, Diagnostic Centers, Ambulatory Surgical Centers
By Region	North America: U.S., Canada, Mexico
	Europe: France, UK, Spain, Germany, Italy, Russia, Rest of Europe
	Asia-Pacific: China, Japan, India, Australia, ASEAN, South Korea, Rest of Asia-Pacific
	Middle East & Africa: Turkey, U.A.E., Saudi Arabia, South Africa, Rest of Middle East & Africa
	South America: Brazil, Argentina, Rest of South America

Market Segmentation

By Product (Systems and Consumables): The consumables segment earned USD 6.32 billion in 2024 due to the high frequency of procedures requiring disposable catheters, guidewires, and contrast media.
By Technology (X-Ray, MRA, CT, and Others): The x-ray segment held a share of 36.22% in 2024, attributed to its widespread availability, lower cost, and real-time imaging capabilities.
By Application (Coronary, Endovascular, Neurovascular, Cerebral, and Others): The coronary segment is projected to reach USD 4.27 billion by 2032, owing to the rising incidence of coronary artery disease and the growing demand for early diagnosis.
By End User (Hospitals, Diagnostic Centers, and Ambulatory Surgical Centers): The hospitals segment is projected to reach USD 6.34 billion by 2032, fueled by the availability of advanced imaging infrastructure and higher patient inflow for complex vascular procedures.

Angiography Devices Market Regional Analysis

Based on region, the market has been classified into North America, Europe, Asia Pacific, Middle East & Africa, and South America.

Angiography Devices Market Size & Share, By Region, 2025-2032

The North America angiography devices market accounted for a substantial share of 34.09% in 2024, valued at USD 3.59 billion. This dominance is reinforced by the high volume of cardiovascular and neurovascular procedures, supported by the early adoption of advanced imaging systems and strong healthcare infrastructure across the U.S. and Canada. Continued investment in precision-guided therapies and digital integration further supported regional market growth.

For instance, in December 2024, Terumo Health Outcomes partnered with Medis Medical Imaging in the U.S. to enhance cardiovascular care by integrating Terumo’s ePRISM clinical decision support platform with Medis’ QFR technology. This collaboration aims to improve workflow efficiency and patient outcomes by enabling non-invasive, angiography-based assessment of coronary physiology, reducing reliance on pressure wires and supporting more informed treatment planning in interventional cardiology.

This initiative exemplifies North America’s innovation-driven approach, enabling non-invasive, angiography-based coronary physiology assessments that enhance diagnostic accuracy, improve workflow efficiency, and reduce reliance on invasive pressure wires in interventional cardiology. Such collaborations strengthen the region's leadership in technological advancement and clinical excellence in angiography .

The Asia-Pacific angiography devices industry is expected to register the fastest CAGR of 5.51% over the forecast period. This growth is propelled by rapid urbanization and the increasing prevalence of cardiovascular diseases, supported by changing lifestyles and dietary habits.

This has led to the increased demand for advanced diagnostic tools. Rising healthcare infrastructure investments, particularly in emerging economies such as India and Southeast Asia, have expanded access to specialized cardiovascular care. Additionally, growing awareness among patients about early diagnosis and minimally invasive procedures has fueled the adoption of angiography devices.

This growth is further aided by the expanding medical tourism industry, as patients seek cost-effective, high-quality cardiac treatments. Furthermore, increasing availability of skilled healthcare professionals and advancements in local manufacturing have improved affordability and accessibility of these devices across the region.

Regulatory Frameworks

In the U.S., the Food and Drug Administration (FDA) is the regulatory authority for angiography devices. They regulate all medical devices, including those used for angiography, to ensure safety and effectiveness.
In the European Union, angiography devices are regulated primarily under the EU Medical Device Regulation (MDR). The MDR ensures the safety, efficacy, and quality of medical devices, including angiography devices.
In Japan, the Pharmaceuticals and Medical Devices Agency (PMDA) serves as the regulatory authority for medical devices, including angiography equipment, in coordination with the Ministry of Health, Labour and Welfare (MHLW) under the PMD Act.

Competitive Landscape

The angiography devices market is characterized by key players adopting strategies to strengthen their market presence. Leading companies are focusing on expanding their product portfolios through the development of advanced and minimally invasive imaging technologies.

Strategic collaborations and partnerships with healthcare providers and research institutions are fostering innovation and boosting clinical adoption. Market participants also prioritize geographic expansion to tap into emerging markets, often through the establishment of regional subsidiaries and distribution networks.

Additionally, mergers and acquisitions are frequently employed to acquire new technologies, enhance manufacturing capabilities, and increase market share.

In October 2024, Siemens Healthineers and the University Hospital Nantes entered into a 12-year Value Partnership agreement worth approximately USD 58 million. The collaboration aims to advance diagnostic and interventional imaging across 13 public hospitals in Loire-Atlantique, including the installation of nine angiography systems to support interventional neurology, cardiology, radiology, and surgery.

List of Key Companies in Angiography Devices Market:

Siemens AG
General Electric Company
Koninklijke Philips N.V.
Canon Inc.
Shimadzu Corporation
Omega Medical Imaging, LLC
Allengers
Boston Scientific Corporation
AngioDynamics
Abbott
B. Braun SE
Cordis
TERUMO CORPORATION
Merit Medical Systems
Alvimedica

Recent Developments (Product Launch)

In September 2024, Royal Philips introduced an enhanced version of its unique LumiGuide endovascular navigation wire, which received FDA approval for clinical use. The new 160cm LumiGuide Navigation Wire expands the application of Philips’ proprietary Fiber Optic RealShape (FORS) technology in complex vascular procedures. Designed to integrate seamlessly with the Philips Azurion Image Guided Therapy System, the wire offers real-time 3D visualization of catheters while minimizing radiation exposure.